Name Net increased
positions
Increased positions Reduced positions Return since
31 Dec ‘16
851
1 4 3 212%
852
1 19 18 8.41%
853
1 5 4 37.4%
CLLS
854
Cellectis
CLLS
$453M
1 9 8 76.5%
855
1 23 22 41.1%
856
1 1 0
857
1 2 1 197%
858
1 29 28 1.05%
859
1 29 28 34%
860
1 30 29 88.8%
AVDL
861
Avadel Pharmaceuticals
AVDL
$1.46B
1 24 23 46.5%
862
1 5 4 450%
863
1 11 10 11.3%
864
1 31 30 83.7%
865
1 1 0 191%
866
1 1 0
867
1 14 13 31.1%
868
1 12 11 69.2%
869
1 2 1 65.3%
870
1 14 13 21.7%
871
1 7 6 66.8%
872
1 4 3 77.3%
873
1 1 0
874
1 4 3 201%
875
1 20 19 14.6%